Fig. 8.
Fig. 8. Constitutive activation of PI-3K/Akt pathway in MO7e cells expressing Asp816 mutant c-Kit. / (A) Different cells as indicated were incubated in 0.5% FCS in the absence of SCF for 5 hours and then stimulated with rhSCF (40 ng/mL) for 5 minutes. Akt protein was immunoprecipitated and the in vitro Akt kinase assay using GSK-3 fusion protein as substrate was carried out as described in “Materials and methods,” followed by Western blot analysis. The blot in the upper panel was probed with antiphospho–GSK-3 antibody. This blot was subsequently stripped and reprobed with anti-Akt antibody, as shown in the lower panel. (B) MO7e cells transduced with wild-type or D816H mutant c-kit were incubated in 0.5% FCS in the absence of SCF for 5 hours. LY294002 (20 μM) was added to some samples as indicated at the fourth hour of the incubation, followed by the experimental procedures as described in panel A.

Constitutive activation of PI-3K/Akt pathway in MO7e cells expressing Asp816 mutant c-Kit.

(A) Different cells as indicated were incubated in 0.5% FCS in the absence of SCF for 5 hours and then stimulated with rhSCF (40 ng/mL) for 5 minutes. Akt protein was immunoprecipitated and the in vitro Akt kinase assay using GSK-3 fusion protein as substrate was carried out as described in “Materials and methods,” followed by Western blot analysis. The blot in the upper panel was probed with antiphospho–GSK-3 antibody. This blot was subsequently stripped and reprobed with anti-Akt antibody, as shown in the lower panel. (B) MO7e cells transduced with wild-type or D816H mutant c-kit were incubated in 0.5% FCS in the absence of SCF for 5 hours. LY294002 (20 μM) was added to some samples as indicated at the fourth hour of the incubation, followed by the experimental procedures as described in panel A.

Close Modal

or Create an Account

Close Modal
Close Modal